“OK, two jabs, but we are not going to do it every year.”
In 2020 or 2022, Naomi Wolf reported that pharma marketing — particularly Pfizer, I think — was enticing investors with this recurrent / annual clot shot necessity. Investors would consider it to be a never-ending stream of profit for them in their portfolios.
They compared it to software updates.
Despicable people.
Pfizer didn’t believe us when we warned them we wouldn’t take more jabs. The Fauchi Ouchey.